Depression is a condition affecting millions across the globe. However, efficient drugs with minimal adverse effects are scarce. Now, researchers have reported how KNT-127, a delta opioid receptor agonist, quickly and efficiently reduces classic parameters of depression in a mouse model. This anti-depressant agent exhibits the dual nature of being a stress reliever and an anti-depressant and could broaden the potential of existing treatments.
Anti-depressant agent KNT-127 reduces stress as well as depression